In his new role he will support and contribute to the creation and implementation of the Company’s long-term growth strategy in collaboration with the management team. See the complete profile on LinkedIn and discover Ryan’s connections and jobs at similar companies.
Prior to joining BioNTech, Ryan was an Executive Director in the Global Healthcare Investment Banking team at J.P. Morgan in London, where he advised companies in the biotech and life sciences industry on M&A, equity and debt capital financings. Ryan holds an MBA from the University of Chicago Booth School of Business, an MSc from the London School of Economics and a BS in Biology from the University of Kansas.BioNTech was founded in 2008 on the understanding that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. Our Mission: broaden the therapeutic universe to benefit patients In addition, Ryan will continue to play a leadership role in the development and execution of BioNTech’s capital markets strategy and will oversee investor relations and external communications functions.“I believe BioNTech has an extraordinary opportunity ahead of it to truly change the way cancer and other serious diseases will be treated in the future and am thrilled to join the Management Board at such an exciting time in the Company’s development,” said Ryan Richardson brings over 15 years of experience in the finance and healthcare industries to BioNTech.
Tour our platforms that produce individually-tailored therapeutics In addition, Ryan will continue to play a leadership role in the development and execution of BioNTech’s capital markets strategy and will oversee investor relations and external communications functions.“I believe BioNTech has an extraordinary opportunity ahead of it to truly change the way cancer and other serious diseases will be treated in the future and am thrilled to join the Management Board at such an exciting time in the Company’s development,” said Ryan Richardson brings over 15 years of experience in the finance and healthcare industries to BioNTech. MAINZ, Germany, Jan. 13, 2020 (GLOBE NEWSWIRE) -- BioNTech SE (NASDAQ: BNTX, “BioNTech” or “the Company”), announced today that the Supervisory Board has appointed Ryan Richardson to the Management Board as Chief Strategy Officer (CSO) and Managing Director. As Chief Strategy Officer, he will be responsible for evaluating new business opportunities and developing BioNTech’s portfolio management function to support an advancing pipeline of more than 20 product candidates. In his new role he will support and contribute … Makes Vaccine Deal; Infections Grip Asia: Virus UpdateArizona Cases Slow; Chicago Tightens Bar Limits: Virus UpdateU.K.
As Chief Strategy Officer, he will be responsible for evaluating new business opportunities and developing BioNTech’s portfolio management function to support an advancing pipeline of more than 20 product candidates.